United States-based Conformal Medical Inc has named George Fazio as its new director, it was reported on Thursday.
Presently, Fazio is the president and chief executive officer of Corvia Medical. He has over three decades of executive experience in the cardiovascular space. He has served in various senior leadership positions with St Jude Medical, including serving as president of the United States and EMEA regions, and both the cardiovascular and cardiac surgery businesses. He also held the position of president of Health Care Services.
Andy Levine, co-founder and chief executive officer of Conformal Medical, said, 'We are very pleased to have George join Conformal's board of directors at this important time as we embark on our US IDE trial. We are confident that his strategic business insights, extensive knowledge in the cardiovascular market, and experience as an executive of a private medical device company will add tremendous value as we advance our technology through upcoming clinical and regulatory milestones.'
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits